Insulin
"Insulin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).
| Descriptor ID |
D007328
|
| MeSH Number(s) |
D06.472.699.587.200.500.625 D12.644.548.586.200.500.625
|
| Concept/Terms |
Insulin- Insulin
- Insulin, Regular
- Regular Insulin
- Soluble Insulin
- Insulin, Soluble
|
Below are MeSH descriptors whose meaning is more general than "Insulin".
Below are MeSH descriptors whose meaning is more specific than "Insulin".
This graph shows the total number of publications written about "Insulin" by people in this website by year, and whether "Insulin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 8 | 6 | 14 | | 1997 | 7 | 6 | 13 | | 1998 | 8 | 8 | 16 | | 1999 | 10 | 11 | 21 | | 2000 | 9 | 9 | 18 | | 2001 | 11 | 9 | 20 | | 2002 | 12 | 6 | 18 | | 2003 | 16 | 13 | 29 | | 2004 | 24 | 22 | 46 | | 2005 | 14 | 16 | 30 | | 2006 | 13 | 23 | 36 | | 2007 | 17 | 30 | 47 | | 2008 | 19 | 21 | 40 | | 2009 | 22 | 40 | 62 | | 2010 | 28 | 15 | 43 | | 2011 | 21 | 27 | 48 | | 2012 | 25 | 34 | 59 | | 2013 | 21 | 27 | 48 | | 2014 | 17 | 39 | 56 | | 2015 | 25 | 29 | 54 | | 2016 | 30 | 30 | 60 | | 2017 | 24 | 34 | 58 | | 2018 | 30 | 35 | 65 | | 2019 | 37 | 36 | 73 | | 2020 | 30 | 36 | 66 | | 2021 | 21 | 46 | 67 | | 2022 | 10 | 74 | 84 | | 2023 | 7 | 51 | 58 | | 2024 | 44 | 28 | 72 | | 2025 | 44 | 17 | 61 | | 2026 | 17 | 17 | 34 |
To return to the timeline, click here.
Below are the most recent publications written about "Insulin" by people in Profiles.
-
Sarbaugh D, Oliveira TG, Guney MA, Casey MR, Hoelscher VM, Hill CJ, Michel CR, Wells KL, Benninger RKP, Sussel L. CHD4 and NKX2.2 Cooperate to Regulate ß-Cell Function by Repressing Non-ß-Cell Gene Programs. Diabetes. 2026 07 01; 75(7):1189-1200.
-
Hitt TA, Kelly A, Stefanovski D, Zemel BS, McCarter R, Yanek L, Zandieh G, Özdemir I, Kamel IR, Hui SCN, Barker P, Magge SN. Insulin Hypersecretion and Increased Ectopic Fat in South Asian American Adolescents and Young Adults Compared With White and African American Peers: The CHARISMA Study. Diabetes Care. 2026 06 01; 49(6):1057-1066.
-
Ciccaglione M, Abenojar E, Kosmides T, DiLisio JE, McDaniel KA, Hartmoore K, Gresch A, Jarrell DK, Ramirez DG, Sticco-Ivins M, Michels AW, Haskins K, Exner AA, Benninger RKP. Submicron-sized ultrasound contrast agents as therapeutic peptide delivery vehicles in type 1 diabetes. Theranostics. 2026; 16(12):6692-6712.
-
Francis EC, Boyle KE, Gyllenhammer LE, Dabelea D, Jansson T, Perng W. Placental insulin-mTOR and stress-inflammatory signaling patterns are associated with childhood adiposity. BMC Med. 2026 May 08; 24(1).
-
Al Rawashdh N, Patel BV, Wang SM, Zur RM, Anaya P, Kahn EB, Pinsker JE, Sasson-Katchalski R, Trahan AC, Messer LH, Assadi K, Kudva YC, Beck RW. Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United States. Diabetes Obes Metab. 2026 Jul; 28(7):6280-6290.
-
Connery L, Rosenstock J, Rasouli N, Cheng AYY, Liebl A, Wang Q, Pires V, Knights A, Davidson MB, Child CJ. Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed-Dose Titration of Weekly Insulin Efsitora in Insulin-Naïve Type 2 Diabetes. Diabetes Obes Metab. 2026 Jul; 28(7):6217-6224.
-
Bluestone JA, Herold KC, Sussel L. Type 1 Diabetes: Advances in Understanding and Treatment 100 Years after the Discovery of Insulin. Cold Spring Harb Perspect Med. 2026 05 01; 16(5).
-
Karakus KE, Akturk HK, Kruger D, Ahmann A, Bharvaga A, Langel CR, Ackeifi CA, Rosen J, Pyle L, Snell-Bergeon JK, Shah VN. Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis. Diabetes Care. 2026 May 01; 49(5):718-723.
-
Beals JW, Smith GI, Farabi SS, Patterson BW, Lucey BP, Broussard JL, Wright KP, Klein S. Sleep Extension Improves Sleep Health but Not Insulin Sensitivity in People With Overweight or Obesity Who Maintain Habitual Short Sleep Schedules. Diabetes Care. 2026 May 01; 49(5):740-745.
-
Seget S, Rusak E, Pelicand J, Fry M, Sheanon N, Schierloh U, Xatzipsalti M, Malinici E, Tinti D, Neylon O, Bazdarska Y, Cobry E, Hauser E. Automated insulin delivery use in children and adolescents with type 1 diabetes across the world. Diabetes Res Clin Pract. 2026 Jun; 236:113253.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|